Eli Lilly Lost 1% Because of the Court’s Damages Order of $3 Billion

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by David Fagan

Eli Lilly Lost 1% Because of the Court’s Damages Order of $3 Billion

PetroQuest Energy Reported First Quarter Production Guidance

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by James Lavish

PetroQuest Energy Reported First Quarter Production Guidance

CONSOL Energy Announced Positive Outlook

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Jared Haas

CONSOL Energy Announced Positive Outlook

Teva Pharmaceutical Got Food and Drug Administration Approval

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Justin Chase

Teva Pharmaceutical Got Food and Drug Administration Approval.

Eldorado Gold Gained 2.7% After Announcing Its New Project

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Lauren Reece

Eldorado Gold Gained 2.7% After Announcing Its New Project

Ixia Jumps Pre-Market on Selection by Microsoft to Qualify Mobile Devices for Use With Lync

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Paul Fletcher

Ixia Jumps Pre-Market on Selection by Microsoft to Qualify Mobile Devices for Use With Lync

Immunomedics Up 5% After Announcing Its New Studies About Development Of Cancer Products

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Robert Fuller

Immunomedics Up 5% After Announcing Its New Studies About Development Of Cancer Products.

NewLead Holdings Soars Pre-Market on Term Sheet Signing for 75% Financing for Two Panamax Dry Bulk Vessels

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Stephen Frank

NewLead Holdings Soars Pre-Market on Term Sheet Signing for 75% Financing for Two Panamax Dry Bulk Vessels.

ABIOMED Adds 3% in Pre-Market – Receives CE Mark for Impella RP

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Alex Hull

ABIOMED Adds 3% in Pre-Market – Receives CE Mark for Impella RP.

BMO Reduced Its Recommendation of BOK Financial

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Annie Barr

BMO Reduced Its Recommendation of BOK Financial.